[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/main/docs/Benef/index.md) >> Individual ID:PBN__Benef_865 

# __Control and prevention of future outbreaks__

## Articles mentionning this Benefit

* [The Socio-Spatial Determinants of COVID-19 Diffusion: The Impact of Globalisation, Settlement Characteristics and Population](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_175.md)

## Category to which it belongs

* [Synonym: proactive surveillance and response to disease transmission, prevention, and control.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_2.md)

## Description of actual returns pertaining to this benefit

* [Private investors in pharmaceuticals and healthcare would benefit from increased demand for vaccines and related products](https://github.com/mm80843/T3.5/blob/pages/BenefReturn/PBN__BenefReturn_948.md)

## Name of the Benefit

Vaccine development and distribution efforts lead to immunization and prevention of future outbreaks

## Risks which can benefit from this action

* [Vaccine development and distribution](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_866.md)

## Stakeholders benefitting from this Benefit

* [Global population](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_278.md)

